Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Haneberg

Showing results (91-100 of 94) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 94 results.
Infection and Immunity|April 7, 1998
Intranasal administration of a meningococcal outer membrane vesicle vaccine induces persistent local mucosal antibodies and serum antibodies with strong bactericidal activity in humansB Haneberg, R Dalseg, E Wedege, et al.
Clinical Genetics|January 1, 1972
Juvenile GM 1 gangliosidosis: clinical, pathological, chemical and enzymatic studiesJ S O'Brien, M W Ho, M L Veath, et al.
Developments in Biological Standardization|April 29, 1998
Towards a nasal vaccine against meningococcal disease, and prospects for its use as a mucosal adjuvantB Haneberg, R Dalseg, F Oftung, et al.
Scandinavian Journal of Immunology|February 28, 2006
Oral spray immunization may be an alternative to intranasal vaccine delivery to induce systemic antibodies but not nasal mucosal or cellular immunityH Bakke, H H Samdal, J Holst, et al.
Pageof 10

Showing results (91-100 of 94) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 94 results.
Infection and Immunity|April 7, 1998
Intranasal administration of a meningococcal outer membrane vesicle vaccine induces persistent local mucosal antibodies and serum antibodies with strong bactericidal activity in humansB Haneberg, R Dalseg, E Wedege, et al.
Clinical Genetics|January 1, 1972
Juvenile GM 1 gangliosidosis: clinical, pathological, chemical and enzymatic studiesJ S O'Brien, M W Ho, M L Veath, et al.
Developments in Biological Standardization|April 29, 1998
Towards a nasal vaccine against meningococcal disease, and prospects for its use as a mucosal adjuvantB Haneberg, R Dalseg, F Oftung, et al.
Scandinavian Journal of Immunology|February 28, 2006
Oral spray immunization may be an alternative to intranasal vaccine delivery to induce systemic antibodies but not nasal mucosal or cellular immunityH Bakke, H H Samdal, J Holst, et al.
Pageof 10